22ND CENTURY GROUP INC (XXII) Stock Overview
USA - NASDAQ:XXII - US90137F5098 - Common Stock
XXII Key Statistics, Chart & Performance
The current stock price of XXII is 1.48 USD. In the past month the price decreased by -24.87%. In the past year, price decreased by -99.55%.
XXII Latest News, Press Relases and Analysis
XXII Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PM | PHILIP MORRIS INTERNATIONAL | 22.39 | 246.03B | ||
| BTI | BRITISH AMERICAN TOB-SP ADR | 10.69 | 112.50B | ||
| MO | ALTRIA GROUP INC | 12.18 | 109.28B | ||
| RLX | RLX TECHNOLOGY INC-ADR | 24 | 2.92B | ||
| TPB | TURNING POINT BRANDS INC | 24.28 | 1.64B | ||
| UVV | UNIVERSAL CORP/VA | 13.06 | 1.34B | ||
| ISPR | ISPIRE TECHNOLOGY INC | N/A | 139.19M |
Related stock screener links
About XXII
Company Profile
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. The company is headquartered in Williamsville, New York and currently employs 56 full-time employees. The company went IPO on 2006-10-17. The firm manufactures and distributes combustible tobacco products containing minimally or non-addictive levels of nicotine. Additionally, the Company provides turnkey contract manufacturing of cigarettes and filtered cigars for other established tobacco brands. The firm's product, VLN cigarette has 95% less nicotine than the traditional cigarette. The firm operates through a single segment named Tobacco. The company is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The company is also engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM.
Company Info
22ND CENTURY GROUP INC
8560 Main St Ste 4
Williamsville NEW YORK 14221 US
CEO: James A. Mish
Employees: 56
Phone: 17162701523
22ND CENTURY GROUP INC / XXII FAQ
What is the stock price of 22ND CENTURY GROUP INC today?
The current stock price of XXII is 1.48 USD.
What is the ticker symbol for 22ND CENTURY GROUP INC stock?
The exchange symbol of 22ND CENTURY GROUP INC is XXII and it is listed on the Nasdaq exchange.
On which exchange is XXII stock listed?
XXII stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for 22ND CENTURY GROUP INC stock?
7 analysts have analysed XXII and the average price target is 5.1 USD. This implies a price increase of 244.59% is expected in the next year compared to the current price of 1.48. Check the 22ND CENTURY GROUP INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is 22ND CENTURY GROUP INC worth?
22ND CENTURY GROUP INC (XXII) has a market capitalization of 5.59M USD. This makes XXII a Nano Cap stock.
How many employees does 22ND CENTURY GROUP INC have?
22ND CENTURY GROUP INC (XXII) currently has 56 employees.
What are the support and resistance levels for 22ND CENTURY GROUP INC (XXII) stock?
22ND CENTURY GROUP INC (XXII) has a resistance level at 1.61. Check the full technical report for a detailed analysis of XXII support and resistance levels.
Is 22ND CENTURY GROUP INC (XXII) expected to grow?
The Revenue of 22ND CENTURY GROUP INC (XXII) is expected to decline by -43.66% in the next year. Check the estimates tab for more information on the XXII EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy 22ND CENTURY GROUP INC (XXII) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of XXII, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of XXII, evaluating the profitability, health, valuation and growth aspects
- 22ND CENTURY GROUP INC (XXII) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- 22ND CENTURY GROUP INC (XXII) Sales and EPS estimates to see what analysts future expectations are.
- 22ND CENTURY GROUP INC (XXII) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- 22ND CENTURY GROUP INC (XXII) Insider and Institutional Ownership to learn about the owners and their transactions.
- 22ND CENTURY GROUP INC (XXII) Stock Chart to make your own analysis
- 22ND CENTURY GROUP INC (XXII) Latest news and press-releases to stay up to date.
Does 22ND CENTURY GROUP INC (XXII) stock pay dividends?
XXII does not pay a dividend.
When does 22ND CENTURY GROUP INC (XXII) report earnings?
22ND CENTURY GROUP INC (XXII) will report earnings on 2025-11-10.
What is the Price/Earnings (PE) ratio of 22ND CENTURY GROUP INC (XXII)?
22ND CENTURY GROUP INC (XXII) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2190.45).
What is the Short Interest ratio of 22ND CENTURY GROUP INC (XXII) stock?
The outstanding short interest for 22ND CENTURY GROUP INC (XXII) is 2.67% of its float. Check the ownership tab for more information on the XXII short interest.
XXII Technical Analysis
XXII Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to XXII. The financial health of XXII is average, but there are quite some concerns on its profitability.
XXII Financial Highlights
Over the last trailing twelve months XXII reported a non-GAAP Earnings per Share(EPS) of -2190.45. The EPS increased by 98.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -99.71% | ||
| ROE | -396.39% | ||
| Debt/Equity | 0 |
XXII Forecast & Estimates
7 analysts have analysed XXII and the average price target is 5.1 USD. This implies a price increase of 244.59% is expected in the next year compared to the current price of 1.48.
For the next year, analysts expect an EPS growth of 93.77% and a revenue growth -43.66% for XXII